We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISTR:NASDAQInvestar Holding Corporation Analysis

Data as of 2026-04-11 - not real-time

$28.54

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Investar Holding Corp (ISTR) is trading at $28.54, comfortably above its 20‑day ($27.30) and 50‑day ($28.21) SMAs and below the 200‑day SMA ($24.95), while the MACD shows a bullish signal and the RSI sits at 62.8, indicating modest upward momentum but approaching overbought levels. Fundamentally, the stock trades at a forward P/E of 8.27 and a trailing P/E of 13.4, well below the industry average P/E of 17.1, and its price‑to‑book ratio of 1.03 suggests near‑fair valuation relative to book value.
The company pays a modest 1.54% dividend with a low 20% payout ratio, supported by positive operating cash flow and a solid ROE of 8.4%. Recent insider buying (1,550 shares) and a “strong buy” consensus from three analysts, who target a median price of $33, provide a clear upside potential of roughly 16% while the DCF‑derived fair value of $15.06 indicates the market is pricing in growth expectations. The stock’s beta of ~0.85 and 30‑day volatility of 19% point to moderate market risk, with decreasing volume suggesting a cautious liquidity environment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance at $28.95
  • RSI approaching overbought territory
  • Decreasing volume trend reducing short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus strong‑buy with median target $33 (+16% upside)
  • Attractive forward P/E of 8.27 and low payout ratio supporting dividend sustainability
  • Insider purchase signaling confidence in near‑term performance

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable regional banking franchise with modest revenue growth (14.8%)
  • Consistent dividend yield and low leverage relative to peers
  • Exposure to regulatory and economic cycles typical of regional banks

Key Metrics & Analysis

Financial Health

Revenue Growth14.80%
Profit Margin24.54%
P/E Ratio13.4
ROE8.45%
ROA0.82%
P/B Ratio1.0
Op. Cash Flow$18.2M
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI62.8
Support$26.25
Resistance$28.95
MA 20$27.30
MA 50$28.21
MA 200$24.95
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$15.06
Target Price$33.17
Upside/Downside16.21%
GradeFair
TypeBlend
Dividend Yield1.54%

Risk Assessment

Beta0.85
Volatility19.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.